August 30, 2010
Bharatbook added a new report on “Pharmaceutical Product Lifecycle Management 2010-2020” which gives commercial and technological developments and analysis of Pharmaceutical Industry.
Pharmaceutical Product Lifecycle Management 2010-2020
– where will the greatest challenges and opportunities lie this decade, and what does the future hold?
The pharmaceutical industry currently faces marked challenges in its long-standing business model. Product lifecycle management (PLM) is being used to maximise the revenue-generating potential of pharmaceuticals, especially in their maturity, but also earlier on. In our new report – Pharmaceutical Product Lifecycle Management 2010-2020 – we examine the PLM strategies that pharmaceutical companies are using. Those measures range from reformulations, new combinations of drugs and expanded indication ranges, to the use of alliances, licensing, mergers and acquisitions. ( http://www.bharatbook.com/detail.asp?id=149103&rt=Pharmaceutical-Product-Lifecycle-Management-2010-2020.html )
In our report we consider the advantages and drawbacks of lifecycle management techniques, as well as approaches such as litigating to protect patents and reducing drug development times. We analyse and discuss conditions within the pharma industry, covering commercial, technological, regulatory and legal aspects. Our study considers where the main opportunities and successes will lie from 2010 onwards. Our research shows that optimised product lifecycle management will be of crucial importance to the pharmaceutical industry from 2010 to 2020. But which techniques will best tackle the decline in revenues and growth prevalent in the sector? Our study tackles such questions, providing the information that you require.
Furthermore, our new report profiles twenty leading drugs that are approaching the ‘patent cliff’ within the next ten years. For those drugs, we investigate and analyse the lifecycle management strategies that companies are using to maximise commercial life and revenue generation. Those leading products include Lipitor, Plavix, Seretide and Seroquel. By analysing approaches the industry is taking, and evaluating the commercial potential for various PLM methods, we provide incisive analysis of pharma PLM activities for this decade.
Comprehensive analysis of pharmaceutical product lifecycle management
Pharmaceutical Product Lifecycle Management 2010-2020 examines that aspect of the pharmaceutical industry and market through a comprehensive review of information sources. We use primary and secondary research. This report provides forward-looking sales analysis, discussions of commercial and technological developments and analysis of market drivers and restraints, including multiple SWOT analyses. There are wide-ranging tables and figures included, as well as a full interview with an authority on the industry. The result is a comprehensive market- and industry-centred study, with detailed analyses and opinion to benefit your work.
For more information kindly visit : http://www.bharatbook.com/detail.asp?id=149103&rt=Pharmaceutical-Product-Lifecycle-Management-2010-2020.html
Big Pharmas Key Lifecycle Management Strategies – Maximizing the Market Potential
2009 Top Product Lifecycle Management Engineered Solutions Vendors, Black Book 2009 Survey Results
Contact us at :
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Follow us on twitter: http://twitter.com/3bbharatbook
Please visit our blog at http://bharatbookseo.blogsome.com
, aggregator, company insight, company profile, company report, Demand Forecast, drugs, lifecycle, management, market forecast, market growth, market leader, market research reports, market share, Pharma